Aurobindo Pharma's Unit-VI passes USFDA inspection

Aurobindo Pharma's Unit-VI completes USFDA inspection. The facility successfully underwent a routine regulatory audit by the US Food and Drug Administration. No observations were reported, indicating compliance with current standards. This clears a key regulatory hurdle for exports to the US market.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #RegulatoryUpdate